Stone Ridge Asset Management LLC purchased a new position in shares of Anthem Inc (NYSE:ANTM) in the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The fund purchased 16,660 shares of the company’s stock, valued at approximately $3,749,000.
Several other institutional investors have also bought and sold shares of ANTM. Viking Global Investors LP grew its position in Anthem by 190.5% during the 4th quarter. Viking Global Investors LP now owns 2,537,576 shares of the company’s stock worth $570,980,000 after acquiring an additional 1,664,112 shares during the last quarter. Allianz Asset Management GmbH grew its position in Anthem by 66.0% during the 4th quarter. Allianz Asset Management GmbH now owns 1,603,619 shares of the company’s stock worth $360,830,000 after acquiring an additional 637,439 shares during the last quarter. Farallon Capital Management LLC grew its position in Anthem by 291.9% during the 4th quarter. Farallon Capital Management LLC now owns 823,000 shares of the company’s stock worth $185,183,000 after acquiring an additional 613,000 shares during the last quarter. Atlantic Trust Group LLC bought a new stake in Anthem during the 3rd quarter worth $88,799,000. Finally, Vulcan Value Partners LLC grew its position in Anthem by 52.1% during the 4th quarter. Vulcan Value Partners LLC now owns 1,327,283 shares of the company’s stock worth $298,652,000 after acquiring an additional 454,892 shares during the last quarter. 88.33% of the stock is owned by institutional investors.
A number of brokerages recently weighed in on ANTM. Barclays began coverage on Anthem in a research report on Thursday. They set an “overweight” rating and a $270.00 price objective on the stock. Royal Bank of Canada restated a “buy” rating on shares of Anthem in a research report on Thursday, January 4th. Wells Fargo & Co boosted their price objective on Anthem from $260.00 to $275.00 and gave the stock an “outperform” rating in a research report on Thursday, February 1st. Credit Suisse Group restated an “outperform” rating and set a $280.00 price objective (up previously from $255.00) on shares of Anthem in a research report on Thursday, February 1st. Finally, Piper Jaffray Companies upgraded Anthem from a “neutral” rating to an “overweight” rating and set a $151.00 price objective on the stock in a research report on Wednesday, January 3rd. Four investment analysts have rated the stock with a hold rating and seventeen have assigned a buy rating to the company’s stock. The company currently has a consensus rating of “Buy” and an average target price of $233.25.
Anthem (NYSE:ANTM) last released its quarterly earnings results on Wednesday, January 31st. The company reported $1.29 EPS for the quarter, beating analysts’ consensus estimates of $1.25 by $0.04. Anthem had a return on equity of 12.29% and a net margin of 4.27%. The firm had revenue of $22.45 billion for the quarter, compared to analyst estimates of $22.17 billion. During the same quarter in the previous year, the company posted $1.76 EPS. The business’s revenue was up 4.5% on a year-over-year basis. equities research analysts expect that Anthem Inc will post 15.09 earnings per share for the current fiscal year.
The business also recently declared a quarterly dividend, which will be paid on Friday, March 23rd. Shareholders of record on Friday, March 9th will be given a $0.75 dividend. This represents a $3.00 dividend on an annualized basis and a dividend yield of 1.29%. The ex-dividend date of this dividend is Thursday, March 8th. This is a positive change from Anthem’s previous quarterly dividend of $0.70. Anthem’s payout ratio is 20.89%.
Anthem declared that its Board of Directors has initiated a share repurchase plan on Thursday, December 7th that allows the company to repurchase $5.00 billion in outstanding shares. This repurchase authorization allows the company to purchase shares of its stock through open market purchases. Shares repurchase plans are generally a sign that the company’s board of directors believes its shares are undervalued.
In other news, SVP Ronald W. Penczek sold 1,966 shares of the business’s stock in a transaction dated Wednesday, March 7th. The stock was sold at an average price of $231.90, for a total value of $455,915.40. Following the transaction, the senior vice president now directly owns 2,132 shares of the company’s stock, valued at approximately $494,410.80. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CFO John E. Gallina sold 24,576 shares of the business’s stock in a transaction dated Monday, March 5th. The shares were sold at an average price of $229.81, for a total value of $5,647,810.56. Following the completion of the transaction, the chief financial officer now directly owns 22,139 shares in the company, valued at $5,087,763.59. The disclosure for this sale can be found here. Insiders sold a total of 200,720 shares of company stock worth $47,512,932 in the last quarter. Corporate insiders own 0.36% of the company’s stock.
COPYRIGHT VIOLATION WARNING: This news story was originally reported by American Banking News and is the sole property of of American Banking News. If you are accessing this news story on another publication, it was illegally copied and reposted in violation of US and international trademark and copyright law. The legal version of this news story can be accessed at https://www.americanbankingnews.com/2018/03/12/16660-shares-in-anthem-inc-antm-purchased-by-stone-ridge-asset-management-llc.html.
Anthem, Inc is a health benefits company. The Company operates through three segments: Commercial and Specialty Business, Government Business and Other. It offers a spectrum of network-based managed care plans to large and small employer, individual, Medicaid and Medicare markets. Its managed care plans include preferred provider organizations; health maintenance organizations; point-of-service plans; indemnity plans and other hybrid plans, including consumer-driven health plans; and hospital only and limited benefit products.
Receive News & Ratings for Anthem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Anthem and related companies with MarketBeat.com's FREE daily email newsletter.